Improved therapeutic composition comprising hepatitis b antigen having s, pre-s1 and pre-s2 protein, aluminium phosphate and interferon-alpha and use thereof for treatment of hepatitis b.
WO2020240278A1
Immunotherapeutic compositions for treatment of glioblastoma multiforme
WO2020099927A1
Immunogenic compositions for treatment of hepatitis b
AU2017298576A1
Vaccine compositions for treatment of Zika virus
CA2982796A1
Vaccine compositions for treatment of zika virus
AU2015221538A1
Methods for preparing vesicles and formulations produced therefrom
WO2015128731A2
Compositions and methods for treatment of hepatitis c
WO2014128568A2
Compositions and methods for treatment of hepatitis c
CN104321444A
Methods for detection of anti-cytomegalovirus neutralizing antibodies
US2015079077A1
Methods and compositions for therapeutic agents
AU2013208693A1
Compositions and methods for treating viral infections
US2014328876A1
Synthetic derivatives of mpl and uses thereof
CN111995664A
Compositions and methods for treating cytomegalovirus
EP2663288A1
Methods for preparing vesicles and formulations produced therefrom
EP2590674A2
Compositions and methods for treating influenza
WO2012006368A2
Compositions and methods for treating influenza
CN107029229A
The method for preparing vesica and the preparation being generated by it
CA2803282A1
Methods for preparing vesicles and formulations produced therefrom
CA2700078A1
Method and kit for detection of hepatitis a virus neutralizing antibodies
